EXEL
Exelixis Inc
NASDAQ: EXEL · HEALTHCARE · BIOTECHNOLOGY
$44.46
-0.51% today
Updated 2026-04-30
Market cap
$11.35B
P/E ratio
16.08
P/S ratio
4.89x
EPS (TTM)
$2.78
Dividend yield
—
52W range
$34 – $50
Volume
2.7M
Exelixis Inc (EXEL) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $332.71M | $395.42M | $412.12M | $401.62M | $343.41M | $360.79M | $393.26M | $721.10M | $503.29M | $327.96M | $332.34M | $597.54M | $655.29M | $1.42B | $1.89B | $2.14B | $2.62B | $3.07B | $2.94B | $2.95B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $210.36M | $262.25M | $283.78M | $271.57M | $230.00M | $183.49M | $228.82M | $432.54M | $266.61M | $167.24M | $178.66M | $470.80M | $484.87M | $897.02M | $1.01B | $1.45B | $1.83B | $1.62B | $1.32B | $1.47B |
| Total liabilities | $275.42M | $304.81M | $326.61M | $457.88M | $507.13M | $589.12M | $302.63M | $424.66M | $437.05M | $442.79M | $436.65M | $508.22M | $370.33M | $134.83M | $199.70M | $258.22M | $405.62M | $583.06M | $678.45M | $703.49M |
| Current liabilities | $108.75M | $111.44M | $132.88M | $189.54M | $207.12M | $199.94M | $92.33M | $81.70M | $87.85M | $171.86M | $52.25M | $270.59M | $115.17M | $105.47M | $142.75M | $204.66M | $337.59M | $324.36M | $394.28M | $403.77M |
| Long-term debt | $106.86M | $108.07M | $105.75M | $74.72M | $40.36M | $170.71M | $176.65M | $322.57M | $335.48M | $262.39M | $381.44M | $0.00 | $408000.00 | $12.10M | — | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-603.78M | $-705.27M | $-791.65M | $-954.50M | $-1.09B | $-1.18B | $-1.11B | $-1.25B | $-1.50B | $-1.77B | $-1.94B | $-1.98B | $-1.83B | $-880.36M | $-559.35M | $-447.57M | $-216.51M | $-34.23M | $-173.35M | $-98.65M |
| Accounts receivable | $7.10M | $22.20M | $6.09M | $1.46M | $11.86M | $5.90M | $30.19M | $2.75M | $3.94M | $4.88M | $5.18M | $40.44M | $81.19M | $178.83M | $119.07M | $160.88M | $282.65M | $214.78M | $237.41M | $265.44M |
| Inventory | $5.44M | $6.08M | $51000.00 | $13000.00 | — | — | $0.00 | $1.00 | $2.89M | $2.38M | $2.62M | $3.34M | $6.66M | $9.84M | $12.89M | $20.97M | $27.49M | $33.30M | $17.32M | $22.39M |
| Goodwill | $67.36M | $67.36M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M | $63.68M |